Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
214 articles
3 of 22
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
11.16.23
8
min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
11.06.23
6
min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
10.27.23
5
min. Read
CPT decisions. Trials: Big Health, Mahana and more
10.20.23
6
min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
10.06.23
5
min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
9.29.23
6
min. Read
CMS: PDTs have potential. Trials: Big, Koko, GAIA
9.22.23
6
min. Read
Limbix acquisition price tag. Akili fully pivots to OTC.
9.15.23
6
min. Read
Big Health seeks FDA clearance. 510(k) Apple Watch-Natural Cycles
9.08.23
7
min. Read
Trials: Click, Akili, Laguna, Omada, Big, Koa
9.01.23
5
min. Read
1 of 22